Finance / Germany
If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Corporate Financing Week please click on the trial link below.
Fresenius Acquires APP Pharmaceuticals
July 2008 | M&A News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Corporate Financing Week please click on the trial link below.
German global healthcare group Fresenius SE made a big step into the US generics on July 7, by agreeing to buy US generics specialist APP Pharmaceuticals in a deal worth an estimated US$3.7bn. On top of the US$23 per share offer, there is also a registered and tradable contingent value right (CVR) worth up to US$6 per share, applicable if APP's adjusted EBITDA exceeds over US$1,267.7mn in the next three years, though the likelihood of this (considering that adjusted EBITDA for 2007 was only US$252.9mn) remains to be seen.